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NHS Health Check (NHSHC) is a national programme to identify and manage cardiovascular disease 
(CVD) risk. Practitioners delivering the programme should be competent in discussing CVD risk, but 
there is evidence of limited understanding of the recommended 10-year percentage CVD risk scores. 
Lifetime CVD risk calculators might improve understanding and communication of risk.  
Aim
To explore practitioner understanding, perceptions and experiences of CVD risk communication in 
NHSHCs when using two different CVD risk calculators.
Design and setting
Qualitative video-stimulated recall (VSR) study with NHSHC practitioners.
Method
VSR interviews were conducted with practitioners who delivered NHSHCs using either the QRISK2 10-
year risk calculator (n=7) or JBS3 lifetime CVD risk calculator (n=8). Data were analysed using reflexive 
thematic analysis.
Results
Findings from analysis of VSR interviews with 15 practitioners (9 Healthcare Assistants, 6 General 
Practice Nurses) are presented by risk calculator. There was limited understanding and confidence of 
10-year risk, which was used to guide clinical decisions through determining low/medium/high risk 
thresholds, rather than as a risk communication tool. Potential benefits of some JBS functions were 
evident, particularly heart age, risk manipulation and visual presentation of risk. 
Conclusions
There is a gap between the expectation and reality of practitioners’ understanding, competencies 
and training in CVD risk communication for NHS Health Check. Practitioners would welcome heart 
age and risk manipulation functions of JBS3 to promote patient understanding of CVD risk, but 
there is a more fundamental need for practitioner training in CVD risk communication. 
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Trial registration: ISRCTN10443908. Registered 7th February 2017.
Keywords: Cardiovascular diseases; Risk; Preventive Medicine; Primary Health Care; Qualitative 
Research
How this fits in
Cardiovascular disease (CVD) risk assessment and communication is central to NHS Health Check. 
Knowledge around practitioners’ associated understanding, confidence and perceptions, and the 
potential of newer CVD risk calculators, could inform changes to improve NHS Health Check 
delivery. This study highlights a mismatch between what practitioners are expected to achieve 
through CVD risk communication in NHS Health Checks and actual levels of understanding and 
confidence.  We report limited understanding and utility of 10-year risk as a risk communication 
tool, and potential benefits of heart age and risk manipulation functions of JBS3. However, there is 
a more fundamental need for practitioner training.
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Background
NHS Health Check (NHSHC) was established to prevent cardiovascular disease (CVD) in adults in 
England aged 40-74 years (1). The most common delivery setting is primary care where practitioners, 
usually General Practice Nurses (GPNs) or Health Care Assistants (HCAs), measure the patient’s CVD 
risk, communicate those results to the patient, discuss CVD risk management, and are expected to 
have associated training and competencies (2,3). 
In keeping with National Institute for Health and Care Excellence (NICE) guidance, standard practice is 
to assess CVD risk using QRISK®2 (or QRISK®3), which estimates patient’s percentage risk of having a 
heart attack or stroke in the next 10 years (4). As Bonner et al. (5) noted, such absolute CVD risk 
estimates were not developed as tools to promote patient understanding, but to guide clinical 
decision-making (e.g. discuss statins where 10-year risk ≥10%) (4). 
Evidence that patients and practitioners have limited understanding of such risk scores (6–9) turned 
attention towards alternative CVD risk metrics. In 2014, the Joint British Societies (JBS) launched the 
JBS3 risk calculator (10,11) with a primary focus on lifetime CVD risk. JBS3 includes several CVD risk 
metrics and functions to address limitations of short-term, absolute risk estimates (e.g. 
underestimation of risk in younger adults; interpreting percentages), and facilitate patient 
understanding and decision-making about CVD risk reduction (Figure 1). Features include:
- Heart age: the estimated age of someone of the same gender, ethnicity, and risk of an annual event, 
but with all other CVD risk factors at ‘optimal’ levels (10) (Figure 1a). Someone with a comparatively 
‘old’ heart age should be motivated to undertake behaviour that can reduce it towards their 
chronological age. Evidence suggests that heart age is more easily communicated to, understood and 
recalled by patients (5,12). A rapid review that included four RCTs of change in lifestyle behaviour or 
risk factors following risk communication using heart (or cardiovascular) age versus absolute risk or 
‘usual care’ reported outcomes that generally favoured heart age (statistically or clinically significant), 
but noted concerns about study quality (13). There is some evidence of benefit for clinical risk factor 
management when heart age is combined with other components (14,15), but overall, randomised 
studies directly comparing heart age to percentage risk do not show that heart age is a motivating risk 
format (16). Moreover, potential limitations of heart age include perceived credibility, negative 
emotional response, and inflated risk perception (5,17). 
- Event-free survival: the age by which an individual might expect to have their first CVD event, based 
on current risk and demographic profile. JBS3 presents this as a visual analogue scale, stating that the 
user can ‘on average expect to survive to age XX without a heart attack or stroke’ (Figure 1b).
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- Percentage chance of survival free of heart attack or stroke: a survival curve, which illustrates the 
decreasing chance of being free of a heart attack or stroke with increasing age (based on current risk 
and demographic profile; Figure 1c).
- Risk score manipulation: explicitly possible in JBS3 through modifying risk factors (e.g. smoking 
status, blood pressure, cholesterol) to demonstrate how intervention can reduced CVD risk. Such 
interactive graphics can be beneficial through engaging individuals with the information, promoting 
understanding and retention (18,19) (Figure 1d).
- Visual displays: a variety of icon array or Cates plots, an image of a heart for heart age, visual analogue 
scales and survival curves, aims to accommodate a range of patient needs and preferences (18), and 
may promote risk-reducing behaviour (20).
**Figure 1 near here**
Health professionals’ experiences of NHSHC have been explored, but not focusing on CVD risk 
communication. A 2017 review included 10 studies reporting the views of health professionals in 
primary care (21) and identified scepticism regarding the effectiveness of NHSHC in moving high risk 
patients towards risk-reducing behaviours. However, few captured views of those delivering the 
NHSHCs and none specifically considered CVD risk communication. A study of 38 video-recorded 
NHSHCs found that QRISK2 was communicated in over 97% of cases, but did not report the extent of 
risk discussion or practitioner understanding (22).
This paper presents data from video-stimulated recall (VSR) interviews with NHSHC practitioners from 
the RIsk COmmunication in NHSHC (RICO) study (23). RICO involved analysis of video-recorded NHSHC 
to understand how CVD risk was communicated when using QRISK2 or JBS3. Published findings from 
the RICO study suggest that: practitioners spend little time discussing CVD risk overall, although 
slightly more when using JBS3 (compared with QRISK2); CVD risk discussions tend to be practitioner-
dominated and more information-giving, than dialogue (24,25); practitioners often miss opportunities 
to engage patients in risk discussion, perhaps indicating a lack of confidence (25). In the RICO study, 
VSR interviews with practitioners were used to explore underlying reasons. VSR interviews are well-
suited to study complex clinician-patient interactions (26,27), described as going beyond fact finding 
and description to generate more meaningful explanations of events in consultations (28). They have 
been used in primary care to study the discussion of various health topics (e.g. osteoarthritis, 
preventive services) (27) and aspects of consultations (e.g. patient vs. clinical perspectives; patient 
response; communication) (26,28)
This paper reports findings from VSR interviews with practitioners from the RICO study. Excerpts from 
video-recorded NHSHCs were used in interviews to prompt recall and reflection, with the aim of 
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exploring practitioner understanding, perceptions and experiences of CVD risk communication in 
NHSHCs using QRISK2 or JBS3 CVD risk calculators.
Methods
Setting and participants
Data were collected as part of the RICO study. Study processes are reported in detail elsewhere (23). 
RICO involved 12 general practices in the West Midlands of England recruited through the Clinical 
Research Network. Practice pairs matched by deprivation (29) were randomised to continue using 
QRISK2 to communicate CVD risk in NHSHCs (usual practice), or to use the JBS3 CVD risk calculator 
following brief introductory training (intervention). Each practice was asked to video-record NHSHCs 
until 20 useable consultations were recorded. Two practices allocated to ‘usual practice’ used 
additional software (Informatica), which had some JBS3 functionalities (e.g. heart age, risk 
manipulation). These data were included as this reflected their usual practice and relevant data are 
highlighted using the term QRISK2+.  
Participants were, therefore, a purposive sample of all 15 of primary care practitioners (9 HCAs; 6 
GPNs) who delivered NHSHCs within the 12 RICO general practices (Table 1). They were invited to take 
part in interviews during practice initiation visits.
Procedures
Semi-structured one-to-one VSR interviews were conducted at the general practice, within two weeks 
of the practitioners’ final recorded NHSHC. After each clinic, researchers (VR, LC) viewed recorded 
NHSHC to identify sections of the consultation to use in VSR interviews. Sections were selected if they 
featured discussion of the CVD risk score, manipulation of the risk score (in the JBS3 group), or 
provision of advice, recommendations, and interventions by the practitioner. Interviews followed a 
pre-piloted process and topic guide, tailored to QRISK2 or JBS3 groups. Practitioners in the QRISK2 
group were shown JBS3 outputs with accompanying explanation and asked to comment, and JBS3 
participants had experience of QRISK2 so were able to comment on both risk calculators; thus, 
practitioners from both groups commented on both CVD risk calculators. 
Two Caucasian female researchers with extensive interview experience conducted interviews: a 
qualified Health Psychologist and Lecturer in Health Psychology (LC); and a Research Associate with a 
background in health psychology and NHSHC research (VR). Prior to the study, the researchers did not 
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have any relationship with participants. No others (i.e., non-participants) were present during 
interviews, which were audio-recorded and transcribed verbatim for analysis.
Analysis
Patient VSR interview transcripts were analysed using inductive reflexive thematic analysis (30,31). 
Transcripts were line-by-line coded by two authors, both female and Caucasian: a senior qualitative 
researcher (NE) and a doctoral researcher with relevant interview experience (SC). They 
independently read and coded two transcripts (13%), with discussion to agree the approach. The 
remaining transcripts were coded and preliminary themes developed by SC, which were discussed 
frequently with CG, VR and NE. The resulting themes and subthemes were reviewed and agreed by 




All 15 practitioners were female, which is typical for a female-dominated workforce (33). Thirteen 
were classified as White British and two as Asian British. The mean time for which practitioners had 
been delivering NHSHC was 4.7 (±2.4) years (range 9 months to 9 years). Six practitioners had received 
no formal NHSHC training. Where training was reported (n=9), it was in general delivery and processes. 
**Table 1 near here**
Mean interview duration was 52.6 (±14.4) minutes (range 28 to 84). Analysis produced two main 
themes relevant to the aim of this paper: ‘communicating CVD risk’ (with four sub-themes) and 
‘understanding CVD risk’ (with two sub-themes). However, to make clear the relevance of findings for 
practice as well as research they are presented by risk calculator rather than by theme. Illustrative 
quotations are labelled to show the practitioner identifier, risk calculator group, and their role (HCA, 
GPN). A full report of the results will be available elsewhere (34).
Qualitative findings
10-year percentage risk calculator (QRISK2)
Practitioners expressed a degree of confidence in communicating to patients their estimated 10-year 
risk (QRISK2): ‘I think I’m confident… I think I deliver it well’ (9.1, QRISK2, HCA). However, there was 
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reported variation in its application. Some practitioners said that they delivered CVD risk information 
to all patients in the same way, ‘like a robot. I think I say the same thing to every patient’ (6.1, QRISK2, 
GPN), removing the opportunity to tailor risk communication to individual patient needs and 
understanding (35). Other practitioners said that they adapted delivery: ‘I try and explain [10-year risk] 
it for the level of the person that is sitting there and adapt it’ (6.2, QRISK2, GPN).
Despite the communication of QRISK2 being mandated in NHSHC (36), there was variation in whether 
or not practitioners chose to do so:
‘[If] you think the patient perhaps is not going to pay any attention to you, they are not going 
to take it in, then no’. (6.2, QRISK2, GPN)
‘I personally always do it… because the whole point of the health check is that you reach that 
number…’ (1.1, JBS3, GPN)
Factors influencing whether or not to tell patients their 10-year CVD risk ‘very much depends on the 
patient’ (6.1, QRISK2, GPN); specifically, their age, perceived ability to understand [due to ‘education’ 
or ‘language barrier[s]’ (11.1, JBS3, HCA)], or the perceived likelihood of engagement. 
‘maybe they do understand, but they don’t care… so they don’t want to know, they don’t want 
to discuss it…’ (3.1, QRISK2, HCA)
There was also a suggestion that NHSHCs provided a lot of information for patients to process, which 
could limit ‘whether they’ve taken any of it in’ (8.2, JBS3, GPN).
Practitioner perceptions of the usefulness of the 10-year risk score was also important. Several saw 
the value of 10-year risk in guiding ’the diagnosis and the referrals’ (2.1, QRISK2+, HCA), but thought 
that ‘giving them a percentage, doesn’t inspire them, doesn’t motivate them’ (1.2, JBS3, HCA). One 
practitioner said that they ‘don’t always know how helpful it is to patients’ (6.2, QRISK2, GPN).
The ways in which practitioners described 10-year risk suggested that it was not used to facilitate 
discussion of CVD risk with patients. Rather, it was described as ‘a quick go-to tool… it’s OK, it’s all that 
we have’ (10.1, QRISK2, GPN), which was used to guide clinical decisions by identifying those with 
elevated risk using thresholds:
‘you have got that 10%... you see it and you think about it, “well they are going to need a 
statin.”’ (6.2, QRISK2, GPN)
Despite expressed confidence around communicating 10-year risk, practitioners often demonstrated 
limited understanding and confidence in explaining the score (beyond determining low/medium/high 
risk thresholds). This could limit how much practitioners engage patients in further discussion of risk: 
‘I feel confident in the way that I give it… but then you are only reading off a piece of paper… I don’t 
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feel that I understand… what the percentage is really’ (1.2, JBS3, HCA). Others felt that they 
understood the risk score, but questioned their ability to communicate it, ‘I can probably babble 
sometimes and think, “Even I didn’t understand that”.’ (12.1, QRISK2+, HCA). 
Critically, practitioners used patient’s verbal and non-verbal reactions to their 10-year risk score, to 
gauge understanding, ‘nodding their head, so I think they all understood what I was trying to say’ (11.1, 
JBS3, HCA). However, they also recognised the limitation.
‘It was based on their reactions, but you did wonder sometimes whether they actually fully 
understood.’ (5.1, JBS3, GPN) 
Practitioners expressed a common feeling that even if patients ‘say they understand the percentage, 
some will, and some won't.’ (12.1, QRISK2+, HCA).
‘they seemed to [understand 10-year risk]… they didn’t say otherwise, but maybe they 
wouldn’t, I don’t know.’ (6.2, QRISK2, GPN)
The lack of confidence in their understanding and that of their patients highlighted a training need, 
which practitioners recognised, ‘There is definitely room for improvement, I can see myself there’ (6.1, 
QRISK2, GPN). Several acknowledged ‘we do need more training in [CVD risk communication]’ (1.1, 
JBS3, GPN).  For those who had received some training, it was limited ‘can’t even really call it on the 
job training’ (1.1, JBS3, GPN) and ‘on how to use the [point of care testing] machine... rather than how 




Event-free survival age appeared to be ‘the hardest one to try and communicate’ (7.1, JBS3, HCA). 
Unlike 10-year risk, event-free survival age does not have thresholds that identify patients as low, 
medium or high risk, which were relied upon as cues for discussion or action.
‘there’s no benchmark to give that comparison to be like “right you can live ‘til 84 and so-and-
so live till 82”, so that one was harder.’ (7.1, JBS3, HCA)
As illustrated above, some practitioners misinterpreted lifetime risk in terms of expected age of 
survival (rather than CVD event-free survival), which could lead to patients being given incorrect or 
misleading information. One practitioner also questioned whether event-free survival age would 
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motivate a patient to make a change if the predicted age the patient is expected to live without a CVD 
event was high. 
‘you have told them that they are going [to] live until they’re 82 without any heart attacks or 
strokes… Is that motivating them… I would say not… Because …they are going get to 82 
without anything happening to them.’ (1.2, JBS3, HCA)
Heart age 
Heart age was perceived positively. Practitioners were confident in communicating heart age, ‘cos it’s 
just the easier one to… explain.’ (8.2, JBS3, GPN). It has inherent benchmarking through comparison 
with chronological age, thought to make it easier than 10-year risk for patients to understand, ‘they 
can get their head around that concept of their [heart] age a lot better than [10-year] risk score’ (7.1, 
JBS3, HCA).
‘they know how old they are and then they are exactly… “oh it's the same age as me”, so I 
think they understood that more.’ (11.1, JBS3, HCA).
In turn, practitioners perceived that heart age could motivate patients by highlighting the need to 
make lifestyle changes, and in particular, they believed that patients liked and responded strongly to 
the ‘visual of heart age’:
‘because it is an actual [heart] when you go onto that screen of heart age. The heart is there, 
you can't escape that and then you have got your age right by it.’ (8.1, JBS3, HCA)
When discussing their limited understanding of 10-year risk, one practitioner stated ‘I prefer the heart 
age’ (1.2, JBS3, HCA).
Risk score manipulation and visual displays
Practitioners were positive about risk factor manipulation and visual displays in JBS3. Those using JBS3 
reported that visual features provided an alternative method to communicate risk to patients, who 
‘said it is quite nice to see visually, [as] opposed to me talking’ (8.1, JBS3, GPN). This was thought to 
improve patient engagement:
‘They actually are interested. They have come closer to me, their body language was good, 
they were looking at that, they did ask questions and they were happy, because I think it was 
visualised.’ (11.1, JBS3, HCA)
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Practitioners perceived that this benefit for patient engagement led to better patient understanding 
by showing the benefits of reducing risk (gain framing), which might be more appropriate when 
discussing prevention:
‘I think they understand more… When you show them that if you bring your blood pressure 
down, your cholesterol down, your weight down… how that can affect the results…. they start 
to think about exercise and lifestyle… it’s like an eye opener to them.’ (4.1, JBS3, HCA)
It was also used to show the consequences of high CVD risk (loss framing), which might be more 
appropriate for those with a family history of CVD. 
‘when I was increasing the blood pressure, or the cholesterol, or if they were a smoker, they 
actually saw the difference and then they were like, “no I won't, and thank God I am not [a 
smoker]”, you know so it was a difference on them as well.’ (11.1, JBS3, HCA)
Again, the VSR prompted some practitioners to appraise their risk communication; for example one 
practitioner described their use of heart age as ‘just sort of abrupt wasn’t it? … There didn’t seem to 
be much of a consultation around it’ (1.2, JBS3, HCA); further evidence of the recognised training need. 
Discussion
Summary
We report data from the first VSR interviews with NHSHC practitioners. Our focus was on their 
understanding, perceptions and experiences of CVD risk communication in NHSHCs using QRISK2 or 
JBS3. Despite apparent confidence in delivering the QRISK2®10-year risk scores, they were not well 
understood by practitioners and were regarded primarily as a means of identifying patients as 
low, medium and high-risk to guide decisions around routine medical follow-up, rather than a 
tool to facilitate a discussion of CVD risk with patients. Ultimately, we observed a lack of 
understanding and confidence in explaining 10-year risk among NHSHC practitioners.  
There was a perception that patients were more responsive to, and therefore more likely to 
display intentions towards risk-reducing behaviours in response to heart age and risk score 
manipulation in JBS3, and that patients liked the visual displays (including the heart age image). 
Some practitioners, however, misunderstood event-free survival age. The lack of thresholds to 
indicate when risk was ‘high’ (as with 10-year risk) and lack of inherent comparison (as with heart age 
vs. chronological age), limited practitioners’ confidence with event-free survival age. 
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None of the practitioners had received specific training in risk communication, six had no training 
at all, and they all recognised this training need.
Strengths and limitations
Strengths of this study included use of VSR to allow practitioners reflection on actual events rather 
than memories (which are subject to recall bias) and how they felt at that time, and allow for specific 
reflection on language used and nuances (e.g. body language and real time reactions) (27,28). In 
addition, our sample included practitioners from general practices in areas that varied in deprivation, 
and who varied in their role (HCA, GPN) and experience. Limitations are recognised. First, all practices 
were based in the West Midlands. We cannot assume that practitioners were representative of the 
wider population who deliver NHSHC. Second, potential benefits of JBS3 could have been undermined 
by practitioners’ lack of familiarity and practice using it. However, those who used JBS3 in the RICO 
study were given a verbal explanation during practice initiation visits, written materials, and a short 
video tutorial on how to use JBS3, and were asked to practice using JBS3 in the NHSHC in advance of 
data collection. Further training was not provided in order to preserve the ecological validity of 
studying how the tool might be used if made available. Third, staffing changes meant that the two 
researchers who completed the VSR interviews (VR, LC) were not able to lead the coding and 
preliminary theme development, but were involved in all subsequent stages. 
Comparison with existing literature
Our findings confirm health professionals’ difficulties in explaining percentage CVD risk (6–9) and 
suggest reasons for the brevity of CVD risk discussion observed in NHSHC (24,25). In particular, 
our data support the existing evidence that, often, practitioners do not understand percentage 
10-year risk sufficiently well for effective risk communication. This is perhaps not surprising. Such 
short-term absolute CVD risk metrics were developed to guide clinical decisions and QRISK2® was 
the standard NICE-recommended tool at the time of this study (4). Practitioners demonstrated a 
concomitant level of understanding; primarily, use of the 10% threshold as a trigger to discuss 
statins. However, this falls short of the expected understanding for CVD risk communication that 
can engender patient understanding and inform person-centred risk management discussions 
(2,3,36). This might relate to the lack of specific training in risk communication, which accords 
with a general training need reported elsewhere (37,38). The apparent benefits of some JBS3 
functionalities support the suggestion that, while absolute risk should guide clinical decisions (5), 
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alternative CVD risk metrics/tools might confer understanding. To address this gap, some general 
practices (four in RICO) use additional software with further functions, risk scores and 
presentations, such as those in JBS3.  
Practitioners’ positive perceptions of heart age supports existing literature that suggests it improves 
comprehension and potential impact. Compared with usual care or alternative risk scores, heart age 
has been identified as easier to communicate (by practitioners), easier to recall (by patients) (5,12). 
However, there remain questions regarding its ability to improve CVD risk factors and lifestyle change 
intentions (13), and some patients question the credibility of heart age (17,39,40). Similar to QRISK2®, 
it is possible that practitioners do not fully understand what heart age means (i.e., the estimated age 
of someone of the same gender and ethnicity, and annual risk of a CVD event, but with optimal risk 
factors), but it is intuitive that an ‘old heart age’ is an undesirable outcome (41). Therefore, unlike 
QRISK2®, a superficial understanding of heart age might be adequate for an informed discussion of 
CVD risk. 
Conversely, practitioners often misinterpreted event-free survival age as predicted age of death. 
Consequently, event-free survival age was not well-explained to patients during NHSHCs (25). A 
paucity of literature examines this metric, and none that is specific to NHSHCs. A 2011 review of 
quantitative studies of CVD risk communication strategies concluded that, compared with time frames 
of more than 10 years, shorter time frames improved accuracy of perceptions of CVD risk and risk-
reducing behavioural intentions (20). Our data suggest that the lack of intrinsic comparison (as with 
heart age) or benchmarking as low, medium or high risk (as with QRISK2®), is part of the problem. It 
prevented a basic interpretation of a risk score as ‘good’ or ‘bad’, ‘low’ or ‘high’, which is possible with 
heart age and 10-year risk, even without fully understanding the score. Despite the theoretical 
benefits of lifetime risk over short-term CVD risk estimates, the utility of event-free survival age was 
undermined through poor understanding. 
Risk score manipulation has potential for application in NHSHC; video-recorded NHSHC suggested that 
it might improve patients’ understanding and appraisal of CVD risk, and improve engagement (25). 
Similarly, interviewed practitioners believed that risk manipulation helped to engage patients in risk 
discussion and that they understood. However, this was based on their reading of how patients 
reacted to information. As we reported elsewhere (25), patient responses to risk information were 
minimal and our participants acknowledged that they did not really know if patients actually 
understand their risk scores. Literature on interactive graphical risk representations indicates 
potential benefits for provoking a more emotional response (42), but highlights the importance of 
user competence (18). In RICO, there were examples of practitioners manipulating inappropriate risk 
factors, such as showing a non-smoker with raised cholesterol how their risk would increase if they 
                               
                             
                     
13
started smoking, rather than showing the benefit of reducing cholesterol (25). Therefore, despite the 
positive perceptions among practitioners, user competence might have limited the impact.
Implications for research and practice 
Implications for commissioners and deliverers of NHSHCs include the need to realign 
expectations of CVD risk communication, and the tools and training to support practitioners. Use 
of QRISK2® 10-year CVD risk to guide clinical decisions, rather than for CVD risk communication, 
is consistent with its original purpose, but not with the expectations of NHSHC. Heart age and risk 
manipulation functions of JBS3 should help practitioners to promote patient understanding of 
CVD risk. However, there is an urgent training need to improve practitioners’ understanding and 
confidence in communicating CVD risk. 
Researchers should explore practitioner competencies and patient needs to inform training. This could 
include mapping practitioner competencies to NHSHC requirements, and designing and testing 
training to address the gaps. 
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a) Heart age b) Event-free survival age
c) Percentage change of survival free of CVD event
d) Risk score manipulation (showing the effect on event-free survival of reducing blood pressure 
and cholesterol)
Figure 1. Example JBS3 outputs (Source: http://www.jbs3risk.com/pages/risk_calculator.htm)
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1 1.1 GPN F WBRI 9 years No formal training 7 72.2
JBS3
1.2 HCA F WBRI 6 years Generic, PoC training 5 65.3
2 QRISK®2 2.1 HCA F WBRI 2.5 years Generic training 22 47.4
3 QRISK®2 3.1 HCA F WBRI 2.5 years
No formal training
(at time of study)
14
28.8
4 JBS3 4.1 HCA F BAME 2 years No formal training 29 47.1
5 JBS3 5.1 GPN F WBRI 8 years Generic training x 2 7 40.3
6 6.1 GPN F WBRI 2 years No formal training 6 36.3
QRISK®2
6.2 GPN F WBRI 6 years




7 JBS3 7.1 HCA F WBRI 5 years
Generic, PoC training
(could not recall details)
20
66.2
8 8.1 HCA F WBRI 5 years Generic training 11 84.0
JBS3
8.2 GPN F WBRI 9 months No formal training 13 58.6
9 QRISK®2 9.1 HCA F WBRI 6 years
Generic training
(could not recall details)
5
45.5
10 QRISK®2 10.1 GPN F WBRI 3 years No formal training 3 45.6
11 JBS3 11.1 HCA F BAME 8 years
Generic x 2
(8 and1 years earlier)
8
53.2




HCA, Health Care Assistant; GPN, General Practice Nurse; WBRI, White British; BAME, British and Minority Ethnic Groups; PoC training, trained to use the point-of-care testing 
machine
